-
公开(公告)号:SE412065B
公开(公告)日:1980-02-18
申请号:SE7300033
申请日:1973-01-02
Applicant: HOFFMANN LA ROCHE
IPC: C07D499/00 , C07D499/60 , C07D501/20 , C07D501/28
-
公开(公告)号:ZA728771B
公开(公告)日:1973-08-29
申请号:ZA728771
申请日:1972-12-12
Applicant: HOFFMANN LA ROCHE
Inventor: FURLENMEIER A , VOGLER K , LANZ P , ZANETTI G
IPC: C07D499/60 , B25C5/02 , B25C5/06 , C07C51/60 , C07D499/00 , C07D
-
公开(公告)号:BR7200305D0
公开(公告)日:1973-12-18
申请号:BR30572
申请日:1972-01-19
Applicant: HOFFMANN LA ROCHE
Inventor: FURLENMEIER A , QUITT P , VOGLER K , LANZ P
IPC: C07D499/12 , A61K31/431 , A61P31/04 , C07D207/28 , C07D207/34 , C07D213/78 , C07D213/79 , C07D213/89 , C07D215/48 , C07D215/50 , C07D217/26 , C07D231/14 , C07D233/90 , C07D239/54 , C07D239/557 , C07D261/18 , C07D263/34 , C07D277/56 , C07D285/06 , C07D307/68 , C07D309/12 , C07D333/38 , C07D499/00 , C07D499/56 , C07D499/60
Abstract: Compounds represented by the following formula WHEREIN A is a substituted or unsubstituted heterocyclic radical and T is a C2-C5 alkyl, alkenyl, cycloproplymethyl, cyclobutylmethyl or cyclopentyl group A PROCESS FOR THEIR PREPARATION AND NOVEL INTERMEDIATES THEREFOR ARE DISCLOSED. These compounds are useful antibiotics.
-
公开(公告)号:ZA7208924B
公开(公告)日:1973-09-26
申请号:ZA7208924
申请日:1972-12-18
Applicant: HOFFMANN LA ROCHE
Inventor: FURLENMEIER A , VOGLER K , LANZ P , QUITT P
IPC: C07D207/32 , C07D207/327 , C07D209/18 , C07D213/55 , C07D257/04 , C07D307/54 , C07D333/24 , C07D499/00 , C07D499/60 , C07D
CPC classification number: C07D207/327 , C07D209/18 , C07D213/55 , C07D257/04 , C07D307/54 , C07D333/24 , C07D499/00 , Y02P20/55
-
公开(公告)号:ZA7208771B
公开(公告)日:1973-08-29
申请号:ZA7208771
申请日:1972-12-12
Applicant: HOFFMANN LA ROCHE
Inventor: FURLENMEIER A , VOGLER K , LANZ P , ZANETTI G
IPC: C07D499/60 , B25C5/02 , B25C5/06 , C07C51/60 , C07D499/00 , C07D
CPC classification number: C07D499/00 , B25C5/0257 , B25C5/06 , C07C51/60 , C07C59/70
-
公开(公告)号:ZA718537B
公开(公告)日:1972-09-27
申请号:ZA718537
申请日:1971-12-21
Applicant: HOFFMANN LA ROCHE
Inventor: FURLENMEIER A , QUITT P , VOGLER K , LANZ P
IPC: C07D499/12 , A61K31/431 , A61P31/04 , C07D207/28 , C07D207/34 , C07D213/78 , C07D213/79 , C07D213/89 , C07D215/48 , C07D215/50 , C07D217/26 , C07D231/14 , C07D233/90 , C07D239/54 , C07D239/557 , C07D261/18 , C07D263/34 , C07D277/56 , C07D285/06 , C07D307/68 , C07D309/12 , C07D333/38 , C07D499/00 , C07D499/56 , C07D499/60 , C07D
Abstract: Compounds represented by the following formula WHEREIN A is a substituted or unsubstituted heterocyclic radical and T is a C2-C5 alkyl, alkenyl, cycloproplymethyl, cyclobutylmethyl or cyclopentyl group A PROCESS FOR THEIR PREPARATION AND NOVEL INTERMEDIATES THEREFOR ARE DISCLOSED. These compounds are useful antibiotics.
-
公开(公告)号:ZA7103845B
公开(公告)日:1972-03-29
申请号:ZA7103845
申请日:1971-06-14
Applicant: HOFFMANN LA ROCHE
Inventor: FURLENMEIER A , VOGLER K , ZANETTI G , LANZ P
IPC: C07C229/38 , C07D207/32 , C07D207/327 , C07D207/46 , C07D309/12 , C07D499/00 , C07D499/60 , C07C
CPC classification number: C07D207/327 , C07C229/38 , C07C317/00 , C07C323/00 , C07D207/46 , C07D309/12 , C07D499/00 , Y02P20/55
-
公开(公告)号:NZ196552A
公开(公告)日:1984-07-06
申请号:NZ19655281
申请日:1981-03-18
Applicant: HOFFMANN LA ROCHE
Inventor: FURLENMEIER A , LANZ P
IPC: A61K31/545 , A61K31/546 , A61P31/04 , C07D253/075 , C07D501/36 , C07D501
-
公开(公告)号:ZA8101845B
公开(公告)日:1982-04-28
申请号:ZA8101845
申请日:1981-03-19
Applicant: HOFFMANN LA ROCHE
Inventor: FURIENMEIER A , LANZ P
IPC: A61K31/545 , A61K31/546 , A61P31/04 , C07D253/075 , C07D501/36 , C07D , A61K
CPC classification number: C07D253/075
-
公开(公告)号:ZA728924B
公开(公告)日:1973-09-26
申请号:ZA728924
申请日:1972-12-18
Applicant: HOFFMANN LA ROCHE
Inventor: FURLENMEIER A , VOGLER K , LANZ P , QUITT P
IPC: C07D207/32 , C07D207/327 , C07D209/18 , C07D213/55 , C07D257/04 , C07D307/54 , C07D333/24 , C07D499/00 , C07D499/60 , C07D
Abstract: 1353578 Penicillins F HOFFMANN-LA ROCHE & CO AG 11 Jan 1973 [12 Jan 1972] 1605/73 Headings C2A and C2C Novel penicillins having the general Formula (I) and salts thereof, wherein T is a C 2-5 alkyl group and R is a furyl, pyrrolyl, thienyl, oxazolyl, isoxazolyl, thiazolyl, pyridyl, pyrimidinyl, tetrazolyl or indolyl group, which groups R can be substituted by halogen, C 1-3 alkyl, C 1-3 alkoxy or C 1-3 alkylthio, are prepared by N-acylating 6- aminopenicillanic acid (having the carboxyl group protected) with an acid of Formula (II) wherein T and R have the aforesaid meanings, or with an N-acylating functional derivative thereof, and cleaving off the carboxyl-protecting group. The carboxyl group may be protected by saltformation or esterification. Functional derivatives of the acid (II) are, e.g. halides, azides, anhydrides, reactive esters and active amides. When the acid itself is used, a condensing agent such as dicyclohexylcarbodiimide is preferably present. The reaction is usually performed in an inert solvent. The acids of Formula (II) above, which are said to be novel, are prepared by reacting an acid of Formula (V) with the benzyl or tert. butyl ester of a compound of Formula IV in the presence of benzenesulphonyl chloride or phosgene, R and T having the aforesaid meanings, to give an ester of Formula (III) wherein B is a benzyl- or tert.butyl-protected carboxyl group and then cleaving off the protecting group, e.g. by hydrogenation or treatment with a strong acid respectively, to give the desired acid (II). The latter may be converted to the corresponding acid chloride with thionyl chloride. Examples are given for preparing the following acids (II): (R)-2-[(2-isopropyl-2H- tetrazol - 5 - yl)acetoxy] - isocaproic acid; (R)-2- [(2-thienyl)acetoxy]isocaproic acid; and (R)-2-[(3- indolyl)acetoxy]isocaproic acid. Pharmaceutical compositions having antibiotic activity against Gram-positive and -negative bacteria comprise a penicillin of Formula (I) hereinbefore or a salt or hydrate thereof, in association with a compatible pharmaceutical carrier.
-
-
-
-
-
-
-
-
-